Tag Archives: Frank Morgan

Brookdale (BKD) Receives a Hold from RBC Capital

In a report issued on September 4, Frank Morgan from RBC Capital maintained a Hold rating on Brookdale (BKD – Research Report), with a price target of $4.00. The company’s shares closed last Friday at $2.90, close to its 52-week

RBC Capital Sticks to Their Buy Rating for Surgery Partners (SGRY)

In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Surgery Partners (SGRY – Research Report), with a price target of $23.00. The company’s shares closed last Thursday at $19.79. According to TipRanks.com, Morgan is

Analysts Are Bullish on Top Healthcare Stocks: Cigna (CI), Molina Healthcare (MOH)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cigna (CI – Research Report), Molina Healthcare (MOH – Research Report) and AbbVie (ABBV – Research Report) with bullish sentiments. Cigna (CI)

Analysts Offer Insights on Healthcare Companies: Cigna (NYSE: CI) and ImmunoGen (NASDAQ: IMGN)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cigna (CI – Research Report) and ImmunoGen (IMGN – Research Report) with bullish sentiments. Cigna (CI) In a report issued on July

Analysts Offer Insights on Healthcare Companies: Universal Health (NYSE: UHS), AbbVie (NYSE: ABBV) and SAGE Therapeutics (NASDAQ: SAGE)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Universal Health (UHS – Research Report), AbbVie (ABBV – Research Report) and SAGE Therapeutics (SAGE – Research Report) with bullish sentiments. Universal

RBC Capital Believes UnitedHealth (NYSE: UNH) Still Has Room to Grow

In a report released yesterday, Frank Morgan from RBC Capital maintained a Buy rating on UnitedHealth (UNH – Research Report), with a price target of $341.00. The company’s shares closed last Thursday at $295.22, close to its 52-week high of